Olmesartan is primarily indicated in conditions like Hypertension, and can also be given in adjunctive therapy as an alternative drug of choice in Diabetic nephropathy, Heart failure., Hypertension (high blood pressure)
|Country of origin||
Drugs that act on renin-angiotensin system can cause fetal injury and death when used in pregnancy. Olmesartan medoxomil should be discontinued as soon as possible once pregnancy is detected. Symptomatic hypotension may occur in patients who are volume- and/or salt-depleted. May be associated with oliguria, progressive azotaemia, and acute renal failure (rare). Patients with bilateral or unilateral renal artery stenosis may have increased risk of severe hypotension and renal insufficiency. , Drug should not be given to Pregnant Mothers, patients suffering from Kidney dysfunction, and Neonates.
Dizziness, headache, abdominal pain, dyspepsia, diarrhoea, gastroenteritis, nausea, hypotension, peripheral oedema, haematuria, UTI, hyperkalaemia, hypertriglyceridemia, hyperuricaemia, elevated liver enzymes, facial edema, angioedema, and rhabdomyolysis.
Olmesartan is contraindicated in conditions like Hepatic impairment, Breast feeding, Dry or painful cough, Pain and inflammation